NCT00549068View on ClinicalTrials.gov

POWER Point of Care Effect on Satisfaction of Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

2,433

Participants

Timeline

Start Date

February 28, 2003

Study Completion Date

November 30, 2004

Conditions
Osteoporosis, Postmenopausal
Interventions
DRUG

Risedronate Sodium (Actonel)

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
collaborator

Procter and Gamble

INDUSTRY

lead

Sanofi

INDUSTRY